Elkins Park, PA, United States of America

Peter C McDonnell


Average Co-Inventor Count = 3.9

ph-index = 7

Forward Citations = 184(Granted Patents)


Location History:

  • Fort Washington, PA (US) (1998 - 1999)
  • US (1999)
  • Elkins Park, PA (US) (1998 - 2002)

Company Filing History:


Years Active: 1998-2002

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Peter C McDonnell

Introduction

Peter C McDonnell, a notable inventor based in Elkins Park, Pennsylvania, has made significant contributions to the field of biotechnology and pharmaceuticals. With a remarkable portfolio of 10 patents, McDonnell's work primarily focuses on the development of innovative therapies aimed at combating inflammatory diseases.

Latest Patents

Among his latest inventions is the patent for "Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins." This invention pertains to drug binding proteins, genes encoding these proteins, and methods for screening pharmaceuticals. It specifically centers on a Cytokine Suppressive Anti-Inflammatory Drug (CSAID) binding protein, along with associated assays that are crucial for the evaluation and characterization of this pharmacological class.

Another notable patent includes the "Interleukin-1 homologue, IL-1H4." This patent outlines the IL-1H4 polypeptides and polynucleotides, as well as methods for producing such polypeptides using recombinant techniques. This work also includes therapeutic applications and diagnostic assays that leverage IL-1H4, further demonstrating McDonnell's impact in his field.

Career Highlights

Peter C McDonnell has worked with renowned organizations such as SmithKline Beecham Corporation, contributing his expertise in the development of innovative pharmaceutical solutions. His career is marked by a commitment to research and development in the biotechnology sector.

Collaborations

Throughout his professional journey, McDonnell has collaborated with prominent colleagues, including Peter R Young and Dean E McNulty. These partnerships have been instrumental in advancing his research and achieving significant milestones in inventiveness.

Conclusion

In summary, Peter C McDonnell stands out as a prolific inventor, with a substantial body of work that enhances our understanding and treatment of inflammatory diseases. His patents not only reflect his innovative spirit but also pave the way for future advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…